期刊文献+

流式荧光技术联合检测多种肿瘤标志物的临床应用 被引量:1

Clinical Application of Flow Cytometry combined with Detection of Multiple Tumor Markers
下载PDF
导出
摘要 目的评价应用流式荧光技术联合检测多种肿瘤标志物在肿瘤的早期诊断的价值。方法使用Luminex200多功能流式点阵检测系统测定分析421例恶性肿瘤患者、372例良性疾病患者和154名门诊健康体检者血清7种肿瘤标志物:甲胎蛋白(AFP)、糖类抗原125(CA125)、CYFRA211、糖类抗原42(CA242)、癌胚抗原(CEA)、β-人绒毛膜促性腺激素(β-HCG)、神经元特异性烯醇化酶(NSE)。结果恶性肿瘤组、良性疾病组、健康体检组阳性率分别为73.63%、28.77%、7.23%。恶性肿瘤组阳性率显著高于良性疾病组和健康体检组(P<0.01);多种肿瘤标志物联合检测对肝癌组、肺癌组、结直肠癌阳性检出率均显著高于其单一肿瘤标志物检测(P<0.01)。结论使用Luminex200多功能流式点阵系统联合检测多种肿瘤标志物可以显著提高恶性肿瘤诊断的敏感性,对肿瘤的早期诊断具有重要的应用价值。 Objective To evaluation flow fluorescence techniques were used to detect the significance of multiple tumor markers for early diagnosis.Method Using Luminex200 Multifunction flow lattice detection system analysis of 421 patients with malignant tumor,372 cases of patients with benign disease and154 cases of outpatient health check-up 7 kinds of serum tumor markers:a fetoprotein(AFP),carbohydrate antigen 125(CA125),CYFRA211,carbohydrate antigen 42(CA242),carcinoembryonic antigen(CEA),beta human chorionic gonadotropin(beta HCG),neuron specific enolization enzyme(NSE).Results malignant tumor,benign disease group and health check-up group positive rate were 73.63%,28.77%and 7.23%.Malignant tumor group were significantly higher than that of benign disease group and health check-up group(P<0.01);cooperative detection of multiple tumor markers for liver cancer,lung cancer,colorectal cancer detection rates were significantly higher than the single tumor markers detection(P<0.01).Conclusion Using Luminex200 multi-functional flow lattice system combined detection of multiple tumor markers can significantly improve the sensitivity of the malignant tumor diagnosis,It has important application value in the early diagnosis of tumor.
作者 梁仲城 李春丽 周培刚 黄艳云 LIANG Zhong-cheng;LI Chun-li;ZHOU Pei-gang;HUANG Yan-yun(Department of Clinical Laboratory, Baise People's Hospital, Baise 533000, China)
出处 《中国医药指南》 2019年第14期131-133,共3页 Guide of China Medicine
关键词 流式荧光技术 多种联合检测 肿瘤标志物 Flow fluorescence technique Multiple joint detection Tumor markers
  • 相关文献

参考文献7

二级参考文献36

  • 1李传保,王建中,吴煦,袁家颖,汪润,张爱玉,赵燕君,屈晨雪,王新华.流式微球技术检测血小板微粒的方法建立及其评价[J].中华医学杂志,2005,85(23):1629-1632. 被引量:5
  • 2World Health Organization. Cancer incidence, mortality and survival by site for 14 regions of the world [ R]. Geneva:Global Programme on Evidence for Health Policy Discussion Paper,2001.
  • 3卫生部.全国健康教育与健康促进工作规划纲要(1005-2010)[R].北京:卫生部,2004.
  • 4World Health Organization. World cancer report [ R]. Geneva: WHO, 2003.
  • 5Tonani M, Carvalho EC. Cancer risk and preventive behavior: persuasion as an intervention strategy [ J ]. Rev Lat Am Enfermagem. 2008,16(5) :864 -870.
  • 6Frieden TR, Myers JE, Krauskopf MS. A public health approach to winning the war against cancer[ J]. Oncologist,2008,17 : 17.
  • 7Seideman J,Peritt D.A novel monoclonal antibody screening method usingthe Luminex-100microsphere system[].Journal of Immunological Methods.2002
  • 8Croft H,Malinowski T,Krizbai L,et al.Use of Luminex xMAP-derived Bio-Plex bead-based suspension array for specific detection of PPV Wand characterization of epitopes on the coat protein of the virus[].Journal of Virological Methods.2008
  • 9LD Giavedoni.Simultaneous detection of multiple cytokines and chemokines from nonhuman primates using luminex technology[].Journal of Immunological Methods.2005
  • 10.Evaluation of the linearity of quantitative measurement procedures:a statistical approach;approved guideline[].NCCLS document EP-A.2003

共引文献175

同被引文献14

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部